| 4BY3 |
1.73 |
Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly from E. coli. |
| 4C6B |
1.656 |
Crystal structure of the dihydroorotase domain of human CAD with incomplete active site, obtained recombinantly from E. coli. |
| 4C6C |
1.451 |
Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly from HEK293 cells. |
| 4C6D |
1.298 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.0 |
| 4C6E |
1.263 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 5.5 |
| 4C6F |
1.261 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.5 |
| 4C6I |
1.35 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.0 |
| 4C6J |
1.299 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.5 |
| 4C6K |
1.478 |
Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 8.0 |
| 4C6L |
1.55 |
Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at pH 6.0 |
| 4C6M |
1.62 |
Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at pH 7.0 |
| 4C6N |
1.899 |
Crystal structure of the dihydroorotase domain of human CAD E1637T mutant bound to substrate at pH 6.0 |
| 4C6O |
1.65 |
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 6.0 |
| 4C6P |
1.518 |
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 7.0 |
| 4C6Q |
1.659 |
Crystal structure of the dihydroorotase domain of human CAD C1613S mutant bound to substrate at pH 7.0 |
| 5G1N |
2.1 |
Aspartate transcarbamoylase domain of human CAD bound to PALA |
| 5G1O |
2.1 |
Aspartate transcarbamoylase domain of human CAD in apo form |
| 5G1P |
3.19 |
Aspartate transcarbamoylase domain of human CAD bound to carbamoyl phosphate |
| 5YNZ |
2.774 |
Crystal structure of the dihydroorotase domain (K1556A) of human CAD |
| 6HFD |
1.86997 |
Human dihydroorotase mutant F1563L apo structure |
| 6HFE |
1.47997 |
Human dihydroorotase mutant F1563T apo structure |
| 6HFF |
1.51 |
Human dihydroorotase mutant F1563Y apo structure |
| 6HFH |
1.44871 |
Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.0 |
| 6HFI |
1.45995 |
Human dihydroorotase mutant F1563A apo structure |
| 6HFJ |
1.2 |
Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.5 |
| 6HFK |
1.45914 |
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 6.5 |
| 6HFL |
1.35 |
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.0 |
| 6HFN |
1.44965 |
Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.5 |
| 6HFP |
1.19823 |
Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.0 |
| 6HFQ |
1.14542 |
Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.5 |
| 6HFR |
1.29949 |
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.0 |
| 6HFS |
1.34905 |
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 6.5 |
| 6HFU |
1.39971 |
Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.5 |
| 6HG1 |
2.12 |
Hybrid dihydroorotase domain of human CAD with E. coli flexible loop in apo state |
